T
T Man Pharmaceutical PCL
SET:TMAN
T Man Pharmaceutical PCL
SET:TMAN
Price:
12.9
THB
Market Closed
Market Cap:
฿5.2B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
T
|
T Man Pharmaceutical PCL
SET:TMAN
|
TH |
|
P
|
Paninvest Tbk PT
XBER:OA9
|
ID |
|
H
|
Hutchison Telecommunications (Australia) Ltd
ASX:HTA
|
AU |
|
Golden Tobacco Ltd
NSE:GOLDENTOBC
|
IN |
|
Enjoei SA
BOVESPA:ENJU3
|
BR |
|
Waypoint REIT Ltd
ASX:WPR
|
AU |
|
T
|
Thu Duc Trading and Import Export JSC
VN:TMC
|
VN |
|
T
|
TAC Consumer PCL
SET:TACC
|
TH |
|
DocuSign Inc
NASDAQ:DOCU
|
US |
|
J
|
Jiangsu Yoke Technology Co Ltd
SZSE:002409
|
CN |
|
Genetic Technologies Ltd
ASX:GTG
|
AU |
|
G
|
Guangdong Rongtai Industry Co Ltd
SSE:600589
|
CN |
|
M
|
Macpower CNC Machines Ltd
NSE:MACPOWER
|
IN |
|
G
|
Gelex Group JSC
VN:GEX
|
VN |
|
C
|
Cathay Biotech Inc
SSE:688065
|
CN |
|
T
|
Tianjin Lisheng Pharmaceutical Co Ltd
SZSE:002393
|
CN |
|
T
|
Thales SA
SWB:CSF
|
FR |
|
Kernel Group Holdings Inc
NASDAQ:KRNL
|
US |
|
B
|
BNP Paribas SA
OTC:BNPQF
|
FR |
|
Roche Holding AG
SIX:RO
|
CH |
|
K
|
Korean Drug Co Ltd
KOSDAQ:014570
|
KR |
|
U
|
Unitrade Industries Bhd
KLSE:UNITRAD
|
MY |
|
Vardhman Acrylics Ltd
NSE:VARDHACRLC
|
IN |
|
Enerplus Corp
TSX:ERF
|
CA |
Balance Sheet
Balance Sheet Decomposition
T Man Pharmaceutical PCL
T Man Pharmaceutical PCL
Balance Sheet Decomposition is not available for
T Man Pharmaceutical PCL
T Man Pharmaceutical PCL
Balance Sheet
T Man Pharmaceutical PCL
T Man Pharmaceutical PCL
Currency: THB
| Dec-2022 | Dec-2023 | Dec-2024 | Dec-2025 | ||
|---|---|---|---|---|---|
| Assets | |||||
| Cash & Cash Equivalents |
307
|
348
|
348
|
399
|
|
| Cash |
307
|
348
|
108
|
396
|
|
| Cash Equivalents |
0
|
0
|
241
|
3
|
|
| Short-Term Investments |
0
|
0
|
450
|
352
|
|
| Total Receivables |
529
|
617
|
617
|
1 038
|
|
| Accounts Receivables |
507
|
578
|
596
|
848
|
|
| Other Receivables |
21
|
39
|
21
|
190
|
|
| Inventory |
358
|
482
|
541
|
613
|
|
| Other Current Assets |
32
|
5
|
4
|
3
|
|
| Total Current Assets |
1 226
|
1 451
|
1 960
|
2 406
|
|
| PP&E Net |
930
|
1 048
|
1 143
|
1 204
|
|
| PP&E Gross |
930
|
1 048
|
1 143
|
1 204
|
|
| Accumulated Depreciation |
603
|
691
|
776
|
768
|
|
| Intangible Assets |
13
|
26
|
34
|
45
|
|
| Long-Term Investments |
42
|
41
|
241
|
40
|
|
| Other Long-Term Assets |
67
|
61
|
77
|
89
|
|
| Total Assets |
2 278
N/A
|
2 627
+15%
|
3 456
+32%
|
3 784
+9%
|
|
| Liabilities | |||||
| Accounts Payable |
333
|
332
|
381
|
508
|
|
| Short-Term Debt |
122
|
151
|
1 080
|
875
|
|
| Current Portion of Long-Term Debt |
27
|
40
|
6
|
5
|
|
| Other Current Liabilities |
617
|
499
|
110
|
166
|
|
| Total Current Liabilities |
1 099
|
1 022
|
1 576
|
1 553
|
|
| Long-Term Debt |
77
|
48
|
65
|
63
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
|
| Other Liabilities |
59
|
38
|
45
|
50
|
|
| Total Liabilities |
1 236
N/A
|
1 108
-10%
|
1 686
+52%
|
1 667
-1%
|
|
| Equity | |||||
| Common Stock |
187
|
246
|
300
|
300
|
|
| Retained Earnings |
549
|
967
|
76
|
423
|
|
| Additional Paid In Capital |
306
|
306
|
1 394
|
1 394
|
|
| Total Equity |
1 042
N/A
|
1 519
+46%
|
1 770
+16%
|
2 117
+20%
|
|
| Total Liabilities & Equity |
2 278
N/A
|
2 627
+15%
|
3 456
+32%
|
3 784
+9%
|
|
| Shares Outstanding | |||||
| Common Shares Outstanding |
400
|
400
|
400
|
400
|
|
Switch to:
Switch to:
See Also
Discover More
